Literature DB >> 17553476

Glucose phosphorylation is required for insulin-dependent mTOR signalling in the heart.

Saumya Sharma1, Patrick H Guthrie, Suzanne S Chan, Syed Haq, Heinrich Taegtmeyer.   

Abstract

OBJECTIVE: Insulin regulates both glucose uptake and postnatal cardiac growth. The anabolic effects of insulin are mediated by the mammalian target of rapamycin (mTOR), an evolutionarily conserved kinase which is also a convergence point between nutrient sensing and cell growth. We postulated that mTOR signalling in the heart requires the metabolism of glucose.
METHODS: We interrogated the insulin-mediated mTOR signalling pathway in response to different metabolic interventions regulating substrate metabolism in the isolated working rat heart and in isolated cardiomyocytes.
RESULTS: Although insulin enhanced Akt activity, phosphorylation of mTOR and its downstream targets (p70S6K and 4EBP1) required the addition of glucose. Glucose-dependent p70S6K phosphorylation was independent of the hexosamine biosynthetic pathway, the AMP kinase pathway, and the pentose phosphate pathway. However, inhibition of glycolysis downstream of hexokinase markedly enhanced p70S6K phosphorylation. Furthermore, 2-deoxyglucose activated p70S6K suggesting that phosphorylation of glucose is required for carbohydrate-mediated mTOR signalling in the heart. Lastly, we also found enhanced p70S6K phosphorylation in the hearts of diabetic rats.
CONCLUSION: Phosphorylation of glucose is necessary for insulin-dependent mTOR activity in the heart, suggesting a link between intermediary metabolism and cardiac growth.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17553476      PMCID: PMC2257479          DOI: 10.1016/j.cardiores.2007.05.004

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  34 in total

Review 1.  Role of mTOR signalling in the control of translation initiation and elongation by nutrients.

Authors:  C G Proud
Journal:  Curr Top Microbiol Immunol       Date:  2004       Impact factor: 4.291

Review 2.  Invited review: intracellular signaling in contracting skeletal muscle.

Authors:  Kei Sakamoto; Laurie J Goodyear
Journal:  J Appl Physiol (1985)       Date:  2002-07

3.  Akt/protein kinase B promotes organ growth in transgenic mice.

Authors:  Tetsuo Shioi; Julie R McMullen; Peter M Kang; Pamela S Douglas; Toshiyuki Obata; Thomas F Franke; Lewis C Cantley; Seigo Izumo
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

Review 4.  Regulation of mammalian translation factors by nutrients.

Authors:  Christopher G Proud
Journal:  Eur J Biochem       Date:  2002-11

Review 5.  Elucidating TOR signaling and rapamycin action: lessons from Saccharomyces cerevisiae.

Authors:  José L Crespo; Michael N Hall
Journal:  Microbiol Mol Biol Rev       Date:  2002-12       Impact factor: 11.056

6.  Rapamycin attenuates load-induced cardiac hypertrophy in mice.

Authors:  Tetsuo Shioi; Julie R McMullen; Oleg Tarnavski; Kimber Converso; Megan C Sherwood; Warren J Manning; Seigo Izumo
Journal:  Circulation       Date:  2003-03-17       Impact factor: 29.690

7.  Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression.

Authors:  Darrell D Belke; Sandrine Betuing; Martin J Tuttle; Christophe Graveleau; Martin E Young; Mark Pham; Dongfang Zhang; Robert C Cooksey; Donald A McClain; Sheldon E Litwin; Heinrich Taegtmeyer; David Severson; C Ronald Kahn; E Dale Abel
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

8.  The development of myocardial insulin resistance in conscious dogs with advanced dilated cardiomyopathy.

Authors:  Lazaros A Nikolaidis; Anthony Sturzu; Carol Stolarski; Dariush Elahi; You-Tang Shen; Richard P Shannon
Journal:  Cardiovasc Res       Date:  2004-02-01       Impact factor: 10.787

Review 9.  Insulin/IGF-I-signaling pathway: an evolutionarily conserved mechanism of longevity from yeast to humans.

Authors:  Michelangela Barbieri; Massimiliano Bonafè; Claudio Franceschi; Giuseppe Paolisso
Journal:  Am J Physiol Endocrinol Metab       Date:  2003-11       Impact factor: 4.310

10.  Atrophic remodeling of the heart in vivo simultaneously activates pathways of protein synthesis and degradation.

Authors:  Peter Razeghi; Saumya Sharma; Jun Ying; Yi-Ping Li; Stanislaw Stepkowski; Michael B Reid; Heinrich Taegtmeyer
Journal:  Circulation       Date:  2003-11-10       Impact factor: 29.690

View more
  38 in total

1.  The combination of the novel glycolysis inhibitor 3-BrOP and rapamycin is effective against neuroblastoma.

Authors:  Alejandro G Levy; Peter E Zage; Lauren J Akers; Maurizio L Ghisoli; Zhao Chen; Wendy Fang; Sankaranarayanan Kannan; Timothy Graham; Lizhi Zeng; Anna R Franklin; Peng Huang; Patrick A Zweidler-McKay
Journal:  Invest New Drugs       Date:  2010-10-05       Impact factor: 3.850

2.  Glucose-6-phosphate isomerase deficiency results in mTOR activation, failed translocation of lipin 1α to the nucleus and hypersensitivity to glucose: Implications for the inherited glycolytic disease.

Authors:  Jorge F Haller; Sarah A Krawczyk; Lubov Gostilovitch; Barbara E Corkey; Raphael A Zoeller
Journal:  Biochim Biophys Acta       Date:  2011-07-21

Review 3.  Metabolism in cardiomyopathy: every substrate matters.

Authors:  Julia Ritterhoff; Rong Tian
Journal:  Cardiovasc Res       Date:  2017-03-15       Impact factor: 10.787

4.  Deficiency of cardiac Acyl-CoA synthetase-1 induces diastolic dysfunction, but pathologic hypertrophy is reversed by rapamycin.

Authors:  David S Paul; Trisha J Grevengoed; Florencia Pascual; Jessica M Ellis; Monte S Willis; Rosalind A Coleman
Journal:  Biochim Biophys Acta       Date:  2014-03-12

Review 5.  The two faces of miR-29.

Authors:  Anna Ślusarz; Lakshmi Pulakat
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2015-07       Impact factor: 2.160

6.  Quantitative PET imaging detects early metabolic remodeling in a mouse model of pressure-overload left ventricular hypertrophy in vivo.

Authors:  Min Zhong; Clayton E Alonso; Heinrich Taegtmeyer; Bijoy K Kundu
Journal:  J Nucl Med       Date:  2013-02-20       Impact factor: 10.057

Review 7.  Nonischemic heart failure in diabetes mellitus.

Authors:  Ashrith Guha; Romain Harmancey; Heinrich Taegtmeyer
Journal:  Curr Opin Cardiol       Date:  2008-05       Impact factor: 2.161

8.  Insulin resistance: marker or mediator?

Authors:  Guha Ashrith; Mohammed F Algahim; Heinrich Taegtmeyer
Journal:  Am J Med       Date:  2009-03       Impact factor: 4.965

9.  Loss of long-chain acyl-CoA synthetase isoform 1 impairs cardiac autophagy and mitochondrial structure through mechanistic target of rapamycin complex 1 activation.

Authors:  Trisha J Grevengoed; Daniel E Cooper; Pamela A Young; Jessica M Ellis; Rosalind A Coleman
Journal:  FASEB J       Date:  2015-07-28       Impact factor: 5.191

Review 10.  Fuel availability and fate in cardiac metabolism: A tale of two substrates.

Authors:  Florencia Pascual; Rosalind A Coleman
Journal:  Biochim Biophys Acta       Date:  2016-03-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.